Q3 EPS Estimate for Intuitive Surgical Decreased by Analyst

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Research analysts at William Blair lowered their Q3 2025 earnings estimates for Intuitive Surgical in a research report issued to clients and investors on Wednesday, July 23rd. William Blair analyst B. Vazquez now anticipates that the medical equipment provider will post earnings per share of $1.58 for the quarter, down from their prior forecast of $1.62. The consensus estimate for Intuitive Surgical’s current full-year earnings is $6.43 per share.

ISRG has been the subject of several other research reports. BTIG Research raised their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research note on Wednesday. Citigroup reaffirmed a “buy” rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Piper Sandler reissued an “overweight” rating and set a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday. Barclays dropped their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Finally, Royal Bank Of Canada boosted their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $592.05.

Intuitive Surgical Stock Performance

ISRG stock opened at $495.86 on Friday. The company has a fifty day moving average price of $529.86 and a 200-day moving average price of $535.13. The company has a market capitalization of $177.73 billion, a P/E ratio of 69.16, a PEG ratio of 5.45 and a beta of 1.64. Intuitive Surgical has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.78 earnings per share.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the business’s stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director directly owned 6,371 shares of the company’s stock, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,798 shares of company stock valued at $3,955,331. Insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Castleark Management LLC boosted its stake in Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock valued at $47,221,000 after acquiring an additional 2,990 shares during the last quarter. Arlington Trust Co LLC boosted its stake in Intuitive Surgical by 34.5% in the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider’s stock valued at $369,000 after acquiring an additional 191 shares during the last quarter. Aaron Wealth Advisors LLC boosted its stake in Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider’s stock valued at $1,243,000 after acquiring an additional 78 shares during the last quarter. Ewing Morris & Co. Investment Partners Ltd. purchased a new position in Intuitive Surgical in the fourth quarter valued at about $454,000. Finally, Longbow Finance SA boosted its stake in Intuitive Surgical by 132.0% in the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider’s stock valued at $9,756,000 after acquiring an additional 11,209 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.